Stem Cells Could Cut High Rate of Cornea Transplant Rejection

September 8, 2014

(Irish Examiner) – Human trials on the effectiveness of using adult stem cells in the fight against cornea transplant rejection could be under way within the next five years. Corneal eye disease is the fourth most common cause of blindness in the world and affects more than 10 million people worldwide. New research from NUI Galway has found that transplant rejection rates could be reduced to as low as 10% by administering a stem cell grown from the bone marrow of adult donors.